Search Results

You are looking at 1 - 10 of 122 items for :

  • "characterization" x
  • Behavioral Sciences x
  • Refine by Access: All Content x
Clear All

characterised by appearance-based preoccupations and accompanying compulsions ( Phillips, 2017 ). In the 5 th edition of the Diagnostic and Statistical Manual of Mental Disorders, BDD is classified as an obsessive-compulsive and related disorder; BDD

Open access

Commentary on: Are we overpathologizing everyday life? A tenable blueprint for behavioral addiction research

The diagnostic pitfalls of surveys: If you score positive on a test of addiction, you still have a good chance not to be addicted

Journal of Behavioral Addictions
Authors: Aniko Maraz, Orsolya Király, and Zsolt Demetrovics

, or cutting scores . Psychological Bulletin , 52 ( 3 ), 194. Müller , K. W. , Beutel , M. E. & Wölfling , K. ( 2014 ). A contribution to the clinical characterization of

Open access

described in four distinct stages ( Gollnhofer & Sillans, 1985 ). The first stage consists primarily of incoherent images devoid of religious significance, while the second stage is characterised by a series of apparitions of menacing looking animals that

Open access

Müller , K. W. , Beutel , M. E. & Wölfling , K. ( 2014 ). A contribution to the clinical characterization of Internet Addiction in a sample of treatment seekers: Validity of assessment, severity of psychopathology and type of co

Open access

visual (e.g., altered colours and shapes) and psychological (e.g., mood and cognition) perception ( Forstmann & Sagioglou, 2017 ). The psychedelic-induced “state” is characterised as consisting of a sense that all things are one, feelings of ineffability

Open access

to the following research questions: What age and gender differences seem to be in the characterised aptitude of the selected sample? What kind

Open access

. Letheby (2015) also claims that psychedelic states can have indirect epistemic benefits via their apparent therapeutic effects. First, he points out that pathologies for which psychedelics show promise, such as depression and addiction, are characterised

Open access

Major depressive disorder (MDD) is a substantial public health issue, affecting over 300 million people worldwide ( Jakobsen, Gluud, & Kirsch, 2019 ). It is characterised by feelings of hopelessness, apathy, anxiety, and has a highly

Open access

classes: classical psychedelics (e.g. Psilocybin, LSD, DMT), entactogens (e.g. MDMA), dissociative anaesthetics (e.g. Ketamine), and atypical hallucinogens (e.g. Ibogaine). Each of these different classes are characterised by unique pharmacological

Open access

promising treatment for opioid dependence, ibogaine. His article provides a characterization of ibogaine's uniqueness as a “privileged scaffold” that provides a basic molecular framework prototypic of a class of compounds that allows for systematic

Open access